MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    12-month therapeutic evaluation of l-dopa carbidopa ascorbic acid solution (LCAS) in a cohort of Advanced Parkinson’s disease in a North-Indian tertiary care hospital

    K. Shukla, N. Sawal (Chandigarh, India)

    Objective: To prescribe LCAS to Parkinson’s disease(PD) patients whose symptoms were not adequately controlled on tablet l-dopa and compare the UPDRS-(I,II,III,IV) ON & OFF on…
  • MDS Virtual Congress 2020

    Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey

    O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)

    Objective: The aim of the present study was to evaluate the outcome of LCIG treatment in advanced PD in Aegean Region of Turkey. Background: Levodopa/carbidopa…
  • MDS Virtual Congress 2020

    Treatment of Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy (MSA) with a wearable Pneumatic Compression Garment utilising Soft Robotics

    N. Sawal, H. Singh, A. Beri (Chandigarh, India)

    Objective: To use a novel Pneumatic Garment device for treatment of nOH in MSA. Background: nOH is present in 66-90% of patients with MSA and…
  • MDS Virtual Congress 2020

    Photophobia and Progressive Supranuclear Palsy

    K. Hay, D. Mohanty, Y. Lin, H. Kang, J. Sellers-Gibson, D. Claassen (Nashville, TN, USA)

    Objective: To characterize the prevalence, symptoms, and severity of light sensitivity in Progressive Supranuclear palsy (PSP)). Background: Photophobia is a commonly encountered clinical symptom in…
  • MDS Virtual Congress 2020

    Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease

    M. Burzhunova, N. Garabova (Moscow, Russian Federation)

    Objective: To identify risk factors and TOAST pathogenic subtypes of ischemic stroke (IS) in patients with Parkinson's disease (PD) . Background: Several studies revealed a increased…
  • MDS Virtual Congress 2020

    Socio-economic determinants of diagnostic latency in Parkinson’s disease patients

    P. Surathi, E. Feinstein (Newark, NJ, USA)

    Objective: Early diagnosis is important in optimal management of patients with Parkinson’s disease (PD). There are several factors which can contribute to delay in diagnosis,…
  • MDS Virtual Congress 2020

    Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature

    N. Merghany, A. Al Hasany (Cairo, Egypt)

    Objective: The purpose of this case report and  literature review  is to increase the awareness of  practicing clinicians regarding  the mosaic clinical pattern this disease…
  • MDS Virtual Congress 2020

    Functional Movement Disorder in Young Athletes: A Retrospective Case Series

    A. Lingaiah, D. Mohanty, M. Jablonski, K. LaFaver (Louisville, KY, USA)

    Objective: To present six young athletes with functional movement disorder (FMD) engaged in competitive high school or college sports. Background: FMD is defined by involuntary…
  • MDS Virtual Congress 2020

    Higher exercise self-efficacy is a predictor of clinically meaningful walking activity change in people with Parkinson disease

    C. Colon-Semenza, J. Zajac, T. DeAngelis, T. Ellis (Boston, MA, USA)

    Objective: To determine which factors at baseline predict responsiveness to a 12 month physical activity intervention in people with Parkinson’s disease (PD). Background: Previous studies…
  • MDS Virtual Congress 2020

    Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease

    B. Lindholm, C.H Brogårdh, P. Hagell, C.H Nilsson (Lund, Sweden)

    Objective: To investigate the association of different aspects of cognitive impairment, depression and anxiety with walking difficulties in daily life in persons with mild PD.…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley